Companies / BOC Sciences / Dilpacimab
BOC Sciences

Dilpacimab | BOC Sciences

Dilpacimab is a dual-variable domain immunoglobulin that targets delta-like ligand 4 (DLL4) and VEGF pathways. Dilpacimab has been used in the research of advanced solid tumors.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.